Medivir is a pharmaceutical company focusing on the development of innovative treatments for cancer.
Medivir focuses on cancers of high unmet medical need to provide benefit to patients who so far have had few treatment options.Our projects >
Medivir leverages collaborations with academic and industrial partners in order to bring specialty knowledge, experience and other capabilities to our projects.Partnership >
Results from investigator-initiated phase II clinical study of remetinostat in patients with squamous cell carcinoma publishedRead more
Medivir to present at the Redeye Life Science DayRead more
Birinapant clinical study initiated by IGM BiosciencesRead more
Partnering is an important element of our business strategy. Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale.